{"log_id": 4124044992866167330, "direction": 0, "words_result_num": 52, "words_result": [{"probability": {"variance": 0.026991, "average": 0.897202, "min": 0.404339}, "location": {"width": 872, "top": 208, "height": 73, "left": 199}, "words": "织感染的、微生物学可评估患者的治愈率在利治疗纽为2633〔79"}, {"probability": {"variance": 0.012831, "average": 0.944428, "min": 0.69125}, "location": {"width": 169, "top": 203, "height": 35, "left": 1134}, "words": "在万古霉素组"}, {"probability": {"variance": 0.005114, "average": 0.965544, "min": 0.766332}, "location": {"width": 183, "top": 281, "height": 35, "left": 205}, "words": "为2433(73%"}, {"probability": {"variance": 0.00126, "average": 0.983552, "min": 0.904179}, "location": {"width": 174, "top": 360, "height": 44, "left": 205}, "words": "糖尿病足感染"}, {"probability": {"variance": 0.032379, "average": 0.888668, "min": 0.381183}, "location": {"width": 1028, "top": 362, "height": 82, "left": 270}, "words": "有临床已证实的复杂性肤和皮肤软组织感染(糖尿病足感染)的成年糖尿病患者"}, {"probability": {"variance": 0.025632, "average": 0.927796, "min": 0.429681}, "location": {"width": 1102, "top": 407, "height": 78, "left": 210}, "words": "机(按照2:1的比例)入选一个多中心、开放的对照临床研究,试验药物静脉或口服给"}, {"probability": {"variance": 0.038214, "average": 0.887969, "min": 0.376604}, "location": {"width": 1102, "top": 447, "height": 80, "left": 210}, "words": "药,总疗程14至28天。一者利唑胺静脉或口尿药60mg每12小时一次:另一组"}, {"probability": {"variance": 0.025286, "average": 0.882584, "min": 0.436673}, "location": {"width": 1102, "top": 487, "height": 80, "left": 210}, "words": "氨西林舒巴静脉蜂约1.5至3或阿莫西林克拉维酸口服50mg至875mg每8至12"}, {"probability": {"variance": 0.025365, "average": 0.891456, "min": 0.470727}, "location": {"width": 1102, "top": 527, "height": 82, "left": 216}, "words": "小时(q8-12h)一次。在氮西林舒巴坦没有上市的国家,静尿给药选用阿莫西林/克拉"}, {"probability": {"variance": 0.019448, "average": 0.899732, "min": 0.392107}, "location": {"width": 1093, "top": 570, "height": 80, "left": 214}, "words": "维酸500m至2g每6小时(qh)药一次,对照纽的惠者如果足部感染部检出MRSA"}, {"probability": {"variance": 0.031634, "average": 0.863342, "min": 0.384393}, "location": {"width": 1100, "top": 610, "height": 80, "left": 221}, "words": "r用静脉给予万古素lg每12小时一次,两组怎者中,如果在感烫部位分离出革兰阴性杆"}, {"probability": {"variance": 0.017627, "average": 0.930743, "min": 0.47254}, "location": {"width": 1091, "top": 653, "height": 80, "left": 219}, "words": "面,可以给予缸曲南1g至2g,每8至12小时一次。所有的患者可以接受适当的辅动治疗"}, {"probability": {"variance": 0.024705, "average": 0.90306, "min": 0.380513}, "location": {"width": 1107, "top": 693, "height": 82, "left": 219}, "words": "治疗尿病足感染的典型措施如:创诚负有术,绝大多数点者接受了此类治疗,意向"}, {"probability": {"variance": 0.019617, "average": 0.916322, "min": 0.46297}, "location": {"width": 1104, "top": 735, "height": 78, "left": 223}, "words": "治疗(ITT)人君包括,241份利奈唑按治疗和120例对照药物治疗的患者:212例86%)"}, {"probability": {"variance": 0.035016, "average": 0.896038, "min": 0.391039}, "location": {"width": 1107, "top": 776, "height": 80, "left": 223}, "words": "利奈唑治疗组者和105例:85%)对照药物治疗患作为床可评估者ITT人群"}, {"probability": {"variance": 0.031811, "average": 0.867012, "min": 0.45591}, "location": {"width": 1093, "top": 818, "height": 78, "left": 228}, "words": "的治盒率、在利余心按治疗红患者为68.5%4155:241).对照药物组为649(77120),评价时"}, {"probability": {"variance": 0.027476, "average": 0.909156, "min": 0.40947}, "location": {"width": 1104, "top": 858, "height": 78, "left": 228}, "words": "将不能判定和缺失的结果归为治疗失败临床可评估的老中综外纠果为不能定和失"}, {"probability": {"variance": 0.038422, "average": 0.857285, "min": 0.388008}, "location": {"width": 1080, "top": 901, "height": 76, "left": 230}, "words": "的忠者)的治愈率,在利东唑[治疗为83%159/192),在对照药物组为3(74/101)"}, {"probability": {"variance": 0.024191, "average": 0.89972, "min": 0.389898}, "location": {"width": 1075, "top": 939, "height": 80, "left": 261}, "words": "项重要的pus-hc分析,针对从感染部位血液中分离出兰阳性菌的志者,利会唑按组"}, {"probability": {"variance": 0.022282, "average": 0.906819, "min": 0.426718}, "location": {"width": 1098, "top": 979, "height": 82, "left": 239}, "words": "21例,对照组6例,较总体研究人群,这些者更少有平发骨髓炎的证没有应用被"}, {"probability": {"variance": 0.026226, "average": 0.887096, "min": 0.41678}, "location": {"width": 1098, "top": 1019, "height": 82, "left": 237}, "words": "禁用的抗生索根据该分析:利杂啤按治疗的语者沂您率为71%(86/121),对照药物组为63"}, {"probability": {"variance": 0.037838, "average": 0.875066, "min": 0.425974}, "location": {"width": 1104, "top": 1064, "height": 78, "left": 237}, "words": "38:60).末根辅治疗对于上述析进行调整微生物学可评估忌者不同病原菌韵治愈率"}, {"probability": {"variance": 0.017058, "average": 0.861205, "min": 0.7306}, "location": {"width": 51, "top": 1149, "height": 24, "left": 243}, "words": "见表"}, {"probability": {"variance": 0.000442, "average": 0.987011, "min": 0.897844}, "location": {"width": 917, "top": 1147, "height": 73, "left": 333}, "words": "表14微生物学可评估的糖尿病足感染成年患者治愈检测随访时的治愈率"}, {"probability": {"variance": 0.00014, "average": 0.987312, "min": 0.97546}, "location": {"width": 111, "top": 1207, "height": 31, "left": 912}, "words": "治愈"}, {"probability": {"variance": 1e-06, "average": 0.998832, "min": 0.997713}, "location": {"width": 89, "top": 1227, "height": 31, "left": 369}, "words": "病原体"}, {"probability": {"variance": 0.00024, "average": 0.983278, "min": 0.955766}, "location": {"width": 172, "top": 1261, "height": 33, "left": 679}, "words": "利奈唑胺nN"}, {"probability": {"variance": 0.005456, "average": 0.967946, "min": 0.773003}, "location": {"width": 212, "top": 1245, "height": 35, "left": 1046}, "words": "对照药物nN(%"}, {"probability": {"variance": 0.048116, "average": 0.81251, "min": 0.392829}, "location": {"width": 111, "top": 1312, "height": 24, "left": 731}, "words": "496378"}, {"probability": {"variance": 0.005316, "average": 0.920527, "min": 0.829709}, "location": {"width": 55, "top": 1297, "height": 26, "left": 1104}, "words": "20/29"}, {"probability": {"variance": 0.05848, "average": 0.860433, "min": 0.378353}, "location": {"width": 199, "top": 1324, "height": 35, "left": 246}, "words": "金萄球菌"}, {"probability": {"variance": 0.006056, "average": 0.901022, "min": 0.758417}, "location": {"width": 116, "top": 1351, "height": 26, "left": 738}, "words": "12/17(71)"}, {"probability": {"variance": 0.019535, "average": 0.90357, "min": 0.662546}, "location": {"width": 60, "top": 1337, "height": 24, "left": 1116}, "words": "2:3("}, {"probability": {"variance": 0.02832, "average": 0.612097, "min": 0.3751}, "location": {"width": 163, "top": 1310, "height": 67, "left": 1266}, "words": "分好"}, {"probability": {"variance": 0.019806, "average": 0.886722, "min": 0.498947}, "location": {"width": 339, "top": 1355, "height": 49, "left": 248}, "words": "甲氧西球金黄色葡萄球菌"}, {"probability": {"variance": 0.001177, "average": 0.959261, "min": 0.890669}, "location": {"width": 105, "top": 1393, "height": 26, "left": 731}, "words": "25/29(86"}, {"probability": {"variance": 0.026269, "average": 0.761206, "min": 0.532046}, "location": {"width": 136, "top": 1409, "height": 31, "left": 252}, "words": "五乳链球菌"}, {"probability": {"variance": 0, "average": 0.98814, "min": 0.98814}, "location": {"width": 107, "top": 1395, "height": 111, "left": 1272}, "words": "★"}, {"probability": {"variance": 0.000204, "average": 0.990966, "min": 0.966227}, "location": {"width": 116, "top": 1494, "height": 35, "left": 254}, "words": "儿童患者"}, {"probability": {"variance": 0.002804, "average": 0.975444, "min": 0.821111}, "location": {"width": 344, "top": 1525, "height": 51, "left": 254}, "words": "革兰阳性微生物所致的感染"}, {"probability": {"variance": 0.033955, "average": 0.870194, "min": 0.362423}, "location": {"width": 1019, "top": 1534, "height": 80, "left": 344}, "words": "项临未研究提了利奈胺用于治疗儿童者草兰阳性所致感染,包氧林耐"}, {"probability": {"variance": 0.042581, "average": 0.805693, "min": 0.385775}, "location": {"width": 1102, "top": 1574, "height": 84, "left": 259}, "words": "药和感的金黄色萄球菌私万古素耐药的屎肠球起的院内获泻性肺炎、复杂诚皮肽"}, {"probability": {"variance": 0.023879, "average": 0.87116, "min": 0.455033}, "location": {"width": 1104, "top": 1612, "height": 89, "left": 263}, "words": "印皮肤组织感染、导管相关性菌血富,际因不叫的菌血症和其迪感染的安全作有效件经"}, {"probability": {"variance": 0.025195, "average": 0.902702, "min": 0.39603}, "location": {"width": 1111, "top": 1657, "height": 84, "left": 261}, "words": "验。儿童惠者的年龄从刚出生11岁,所的感染已让实或怀定击革兰阳性菌所,患者"}, {"probability": {"variance": 0.024348, "average": 0.909001, "min": 0.366647}, "location": {"width": 1104, "top": 1699, "height": 82, "left": 266}, "words": "被入选一个随机,开放的、阳性药物对照的临床研究中一组患考每8小时按10mg/kg"}, {"probability": {"variance": 0.033715, "average": 0.894649, "min": 0.367791}, "location": {"width": 1107, "top": 1740, "height": 84, "left": 268}, "words": "静脉注利东唑胺,随后改为每8小时按10mgkg口利唑版混剂。第二思者根据"}, {"probability": {"variance": 0.021338, "average": 0.866255, "min": 0.474383}, "location": {"width": 1109, "top": 1780, "height": 84, "left": 266}, "words": "年龄和肾清除率,按10-15 mg kg每6-24小时静脉输注万古霉索。正实为万古霉索的药的场"}, {"probability": {"variance": 0.042735, "average": 0.85031, "min": 0.391245}, "location": {"width": 1098, "top": 1820, "height": 87, "left": 275}, "words": "球感染的者入远第三组,每8小时按10mkg静注或口服利条全I。所有的患治疗"}, {"probability": {"variance": 0.015932, "average": 0.914093, "min": 0.584528}, "location": {"width": 1024, "top": 1865, "height": 82, "left": 277}, "words": "1-28天,如有临床指可合开应用针对平兰阴性菌感染的抗生系,在意向治疗的患者"}, {"probability": {"variance": 0.030592, "average": 0.885232, "min": 0.352911}, "location": {"width": 1011, "top": 1907, "height": 80, "left": 277}, "words": "人中,206例者机入选利奈唑组,102创患者机入选万毒素组117例"}, {"probability": {"variance": 0.037384, "average": 0.851183, "min": 0.38935}, "location": {"width": 1181, "top": 1941, "height": 89, "left": 279}, "words": "奈唑组的总者和55例5%)万古穿素组的患名为临床可评估惠者意向治疗意"}, {"probability": {"variance": 0.02385, "average": 0.906642, "min": 0.504618}, "location": {"width": 194, "top": 2026, "height": 35, "left": 733}, "words": "第17页,25页"}], "language": 3}